Vimian Group AB (FRA:0V0)
€ 3.615 -0.055 (-1.5%) Market Cap: 1.91 Bil Enterprise Value: 2.12 Bil PE Ratio: 709.02 PB Ratio: 2.98 GF Score: 60/100

Full Year 2023 Vimian Group AB Earnings Call Transcript

Feb 15, 2024 / 08:00AM GMT
Release Date Price: €2.53 (-0.38%)
Patrik Eriksson;publ;CEO
Vimian Group AB

()-

Good morning and thank you very much for joining us today and welcome to the Vimian Q4 and yearend earnings call. I'm Patrik Eriksson and I joined Vimian as the CEO in January.

With me here today is our CFO, Carl-Johan Zetterberg, who will present the quarterly results and [Julie Sperry] CEO. of Navarra, who will give you an update on our MedTech segment. I've been we've been there now for a few weeks spending most of my time getting to know the business solely visiting our different sites and our customers the veterinary clinics. I've met a committed and highly dedicated team. I think we have a strong product portfolio of well-known brands with attractive exposure to high-growth market niches and strong relationships with veterinary community, including several key opinion leaders.

I've spent the past 20 years of my career leading global MedTech businesses with up to $1.5 billion in revenue for almost a decade. I worked for Danaher, a New York stock listed company, which has very many similarities with Vimian

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot